MoonLake Immunotherapeutics
Related Filers (38)
- Chen Bihua (10)
- Bodenstedt Matthias (6)
- CITADEL ADVISORS LLC (5)
- Sturge Simon (5)
- Reich Kristian (5)
- BIOTECHNOLOGY VALUE FUND L P (4)
- Xavier Ramnik (4)
- Phillips Andrew John (4)
- Moukheibir Catherine (4)
- Helix Holdings LLC (3)
- Merck Healthcare KGaA (3)
- FMR LLC (3)
- ADAGE CAPITAL PARTNERS GP, L.L.C. (3)
- PRICE T ROWE ASSOCIATES INC /MD/ (3)
- Santos da Silva Jorge (3)
- RA CAPITAL MANAGEMENT, L.P. (2)
- BlackRock Inc. (2)
- BVF PARTNERS L P/IL (2)
- BVF GP HOLDINGS LLC (2)
- BVF Partners OS Ltd. (2)
- BVF I GP LLC (2)
- BIOTECHNOLOGY VALUE FUND II LP (2)
- LAMPERT MARK N (2)
- BVF INC/IL (2)
- BVF II GP LLC (2)
- Biotechnology Value Trading Fund OS LP (2)
- Loy Spike (2)
- Cormorant Private Healthcare Fund IV LP (2)
- Cormorant Private Healthcare Fund III LP (2)
- Cormorant Global Healthcare Master Fund, LP (2)
- Cormorant Private Healthcare Fund II, LP (2)
- Cormorant Asset Management, LP (2)
- Scollins Jay (1)
- Lewis Will (1)
- Schmid John P. (1)
- CHANG NANCY T (1)
- RTW INVESTMENTS, LP (1)
- Lassen Kara (1)
- Show More ...
Financials (16)
10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/10/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Monday, 3/20/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 11/14/2022
Quarterly Report for period ending 2022-09-30
10-Q
Friday, 8/12/2022
Quarterly Report for period ending 2022-06-30
10-Q
Monday, 5/16/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 2/17/2022
Annual Report for period ending 2021-12-31
10-K/A
Tuesday, 12/14/2021
Annual Report for period ending 2020-12-31
10-Q/A
Tuesday, 12/14/2021
Quarterly Report for period ending 2021-09-30
10-Q
Friday, 11/12/2021
Quarterly Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Friday, 5/21/2021
Quarterly Report for period ending 2021-03-31
NT 10-Q
Tuesday, 5/18/2021
Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2021-03-31
10-K
Wednesday, 3/31/2021
Annual Report for period ending 2020-12-31
10-Q
Thursday, 12/3/2020
Quarterly Report for period ending 2020-09-30
News (26)
8-K
Tuesday, 11/14/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Monday, 10/16/2023
Current report filing
8-K
Monday, 9/11/2023
Current report filing
8-K
Friday, 9/1/2023
Current report filing
8-K
Thursday, 8/10/2023
Current report filing
8-K
Thursday, 6/29/2023
Current report filing
8-K
Monday, 6/26/2023
Current report filing
8-K
Wednesday, 6/7/2023
Current report filing
8-K
Friday, 5/19/2023
Current report filing
8-K
Wednesday, 4/19/2023
Current report filing
8-K
Monday, 3/20/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Friday, 6/17/2022
Current report filing
8-K
Tuesday, 6/7/2022
Current report filing
8-K/A
Monday, 5/16/2022
Current report filing
8-K
Monday, 4/11/2022
Current report filing
8-K
Thursday, 3/31/2022
Current report filing
8-K
Thursday, 3/24/2022
Current report filing
8-K
Friday, 2/25/2022
Current report filing
8-K
Friday, 12/3/2021
Current report filing
8-K
Monday, 10/4/2021
Current report filing
8-K
Monday, 5/3/2021
Current report filing
8-K
Wednesday, 2/24/2021
Current report filing
8-K
Wednesday, 10/28/2020
Current report filing
8-K
Thursday, 10/22/2020
Current report filing
Other (28)
144
Thursday, 2/15/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 2/14/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/20/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/19/2023
Filing for proposed sale of securities under Rule 144
EFFECT
Monday, 9/11/2023
Notice of Effectiveness
CORRESP
Thursday, 9/7/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Tuesday, 5/9/2023
Notice of Effectiveness
CORRESP
Friday, 5/5/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 5/4/2023
Notice of Effectiveness
POS AM
Monday, 5/1/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
ARS
Wednesday, 4/26/2023
Annual report to security holders
EFFECT
Monday, 3/27/2023
Notice of Effectiveness
POS AM
Monday, 3/20/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
EFFECT
Tuesday, 8/2/2022
Notice of Effectiveness
CORRESP
Friday, 7/29/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 7/26/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 7/15/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 2/11/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 2/3/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 1/20/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 12/15/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 12/14/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERT
Tuesday, 10/20/2020
Certification by an exchange approving securities for listing
8-A12B
Monday, 10/19/2020
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
EFFECT
Monday, 10/19/2020
Notice of Effectiveness
CORRESP
Thursday, 10/15/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 10/15/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 10/1/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Ownership (69)
4
Friday, 2/16/2024
Reich Kristian: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/15/2024
Merck Healthcare KGaA: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Chen Bihua: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CITADEL ADVISORS LLC: Major Shareholders
SC 13G
Friday, 2/9/2024
FMR LLC: Major Shareholders
4
Thursday, 12/21/2023
Bodenstedt Matthias: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
Cormorant Asset Management, LP: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
Cormorant Asset Management, LP: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Santos da Silva Jorge: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Bodenstedt Matthias: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Sturge Simon: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Reich Kristian: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Chen Bihua: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/30/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Wednesday, 6/28/2023
Chen Bihua: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Phillips Andrew John: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Sturge Simon: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Moukheibir Catherine: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Loy Spike: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Xavier Ramnik: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
Bodenstedt Matthias: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
Reich Kristian: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 3/31/2023
Chen Bihua: Major Shareholders
4
Wednesday, 3/22/2023
Chen Bihua: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
CITADEL ADVISORS LLC: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13G/A
Friday, 1/27/2023
Merck Healthcare KGaA: Major Shareholders
SC 13G
Wednesday, 8/3/2022
Merck Healthcare KGaA: Major Shareholders
4
Thursday, 5/5/2022
Moukheibir Catherine: Statement of changes in beneficial ownership of securities
4
Thursday, 5/5/2022
Sturge Simon: Statement of changes in beneficial ownership of securities
4
Thursday, 5/5/2022
Xavier Ramnik: Statement of changes in beneficial ownership of securities
4
Thursday, 5/5/2022
Phillips Andrew John: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 4/18/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
3
Friday, 4/15/2022
Bodenstedt Matthias: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Sturge Simon: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Lassen Kara: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Reich Kristian: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Loy Spike: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Moukheibir Catherine: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
BIOTECHNOLOGY VALUE FUND L P: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Santos da Silva Jorge: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Phillips Andrew John: Initial statement of beneficial ownership of securities
3
Friday, 4/15/2022
Xavier Ramnik: Initial statement of beneficial ownership of securities
4
Thursday, 4/7/2022
Chen Bihua: Statement of changes in beneficial ownership of securities
4
Thursday, 4/7/2022
Helix Holdings LLC: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Monday, 2/14/2022
CITADEL ADVISORS LLC: Major Shareholders
SC 13G/A
Thursday, 2/3/2022
BlackRock Inc.: Major Shareholders
SC 13G
Friday, 12/10/2021
FMR LLC: Major Shareholders
SC 13G/A
Monday, 11/15/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
CITADEL ADVISORS LLC: Major Shareholders
SC 13G
Tuesday, 2/16/2021
RTW INVESTMENTS, LP: Major Shareholders
SC 13G/A
Thursday, 2/11/2021
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
SC 13G
Monday, 2/8/2021
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 11/2/2020
CITADEL ADVISORS LLC: Major Shareholders
SC 13G
Monday, 11/2/2020
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
4
Thursday, 10/22/2020
Helix Holdings LLC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/22/2020
Chen Bihua: Statement of changes in beneficial ownership of securities
3
Monday, 10/19/2020
CHANG NANCY T: Initial statement of beneficial ownership of securities
3
Monday, 10/19/2020
Scollins Jay: Initial statement of beneficial ownership of securities
3
Monday, 10/19/2020
Lewis Will: Initial statement of beneficial ownership of securities
3
Monday, 10/19/2020
Chen Bihua: Initial statement of beneficial ownership of securities
3
Monday, 10/19/2020
Helix Holdings LLC: Initial statement of beneficial ownership of securities
3
Monday, 10/19/2020
Schmid John P.: Initial statement of beneficial ownership of securities
Prospectus (24)
S-3
Thursday, 8/31/2023
Registration statement for specified transactions by certain issuers
424B5
Thursday, 6/29/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Tuesday, 6/27/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Monday, 6/26/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 5/11/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Monday, 5/1/2023
Registration statement for specified transactions by certain issuers
424B3
Tuesday, 3/28/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Monday, 11/14/2022
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Friday, 9/30/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Friday, 8/12/2022
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Tuesday, 8/2/2022
Prospectus filed pursuant to Rule 424(b)(3)
S-1/A
Tuesday, 7/26/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 7/15/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 5/2/2022
General form of registration statement for all companies including face-amount certificate companies
425
Thursday, 3/24/2022
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-1/A
Monday, 3/14/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 3/8/2022
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 2/11/2022
General form of registration statement for all companies including face-amount certificate companies
425
Wednesday, 2/24/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B4
Wednesday, 10/21/2020
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Friday, 10/16/2020
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 10/14/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Thursday, 10/1/2020
General form of registration statement for all companies including face-amount certificate companies
DRS
Friday, 8/28/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (15)
DEF 14A
Wednesday, 4/26/2023
Definitive proxy statements
DEFA14A
Wednesday, 4/26/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Friday, 3/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 3/24/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFR14A
Friday, 3/4/2022
Definitive revised proxy soliciting materials
DEFA14A
Friday, 2/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFM14A
Monday, 2/14/2022
Definitive proxy statement relating to a merger, acquisition, or disposition
PRER14A
Friday, 2/11/2022
Preliminary revised proxy soliciting materials
PRER14A
Thursday, 2/3/2022
Preliminary revised proxy soliciting materials
PRER14A
Friday, 1/21/2022
Preliminary revised proxy soliciting materials
DEFA14A
Wednesday, 1/19/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRER14A
Thursday, 12/16/2021
Preliminary revised proxy soliciting materials
PREM14A
Friday, 10/29/2021
Preliminary proxy statement relating to a merger, acquisition, or disposition
DEFA14A
Thursday, 10/28/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 10/4/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.